Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
boston blog main
3
×
boston top stories
life sciences
national blog main
new york blog main
3
×
san francisco blog main
startups
vc
boston
deals
fda
indiana blog main
national top stories
new york top stories
raleigh-durham blog main
san diego blog main
san francisco top stories
seattle blog main
venture capital
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
arrowmark partners
asklepios biopharmaceutical
azacitidine
beta bionics
beta-thalassemia
bigfoot biomedical
bioeurope
biogen
biomarin pharmaceutical
boston university
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer
cara therapeutics
What
developing
3
×
medicines
new
startup
activity
aims
approach
approvals
based
beta
bio
biogen
bionics
biotech
blood
called
clamped
closed
covid
debuts
delays
device
diabetes
driven
drugs
economic
epigenetic
epigenetics
fast
fda
field
flagship’s
heads
including
ipo
isn’t
key
levels
lot
manages
Language
unset
Current search:
biotech
×
developing
×
" new york blog main "
×
" boston blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests